A 3-basepair deletion in repeat 1 of the LDL receptor promoter reduces transcriptional activity in a South African Pedi

Journal of Lipid Research

Volumn 39, Issue 5, 1998, Pages 1021-1024

  Peeters, Armand V ^a   Kotze, Maritha J ^a   Scholtz, Charlotte L ^a   De Waal, Linda F ^a,b   Rubinsztein, David C ^b,f   Coetzee, Gerhard A ^b   Zuliani, Giovanni ^c,g   Streiff, Raphael ^d   Liu, Jingwen ^e   Van Der Westhuyzen, Deneys R ^b,h  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d Boise VA Medical Center   (United States)

^e VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^f CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^g Istituto di Medicina Interno II   (Italy)

^h UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

FH; LDL receptor; Promoter

Indexed keywords

LUCIFERASE;

ALLELE; ARTICLE; BINDING SITE; CASE REPORT; CELL CULTURE; DNA FOOTPRINTING; ENZYME ANALYSIS; EXON; FAMILIAL HYPERCHOLESTEROLEMIA; FRAMESHIFT MUTATION; GENE MUTATION; HUMAN; MALE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE;

AFRICAN CONTINENTAL ANCESTRY GROUP; ARTERIOSCLEROSIS; DNA; DNA FOOTPRINTING; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; PROMOTER REGIONS (GENETICS); RECEPTORS, LDL; SEQUENCE DELETION; SOUTH AFRICA; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); XANTHOMATOSIS;

EID: 15144341366     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Goldstein, J. L., H. H. Hobbs, and M. S. Brown. 1995. Familial hypercholesterolemia. In The Metabolic Basis of Inherited Disease. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle. editors. McGraw-Hill, New York. 1981-2030.
2. Hobbs, H. H., M. S. Brown, and J. L. Goldstein. 1992. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum. Mutat. 1: 445-466.
3. Südhof, T. C., D. R. van der Westhuyzen, J. L. Goldstein, M. S. Brown, and D. W. Russell. 1987. Three direct repeats and a TAT-like sequence are required for regulated expression of the human low density lipoprotein receptor gene. J. Biol. Chem. 262: 10773-10779.
4. Dawson, P. A., S. L. Hofmann, D. R. van der Westhuyzen, T. C. Südhof, M. S. Brown, and J. L. Goldstein. 1988. Sterol-dependent repression of low density lipoprotein receptor promoter mediated by 16-base pair sequence adjacent to binding site for transcription factor Sp1. J. Biol. Chem. 263: 3372-3379.
5. Yokoyama, C., X. Wang, M. R. Briggs, A. Admon, J. Wu, X. Hua, J. L. Goldstein, and M. S. Brown. 1993. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell. 75: 187-197.
6. Wang, X., R. Sato, M. S. Brown, X. Hua, and J. L. Goldstein. 1994. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell. 77: 53-62.
7. Koivisto, U. M., J. J. Palvimo, O. A. Janne, and K. Kontula. 1994. A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA. 91: 10526-10530.
8. Sun, X. M., C. Neuwirth, D. P. Wade, B. L. Knight, and A. K. Soutar. 1995. A mutation (T-45C) in the promoter region of the low-density-lipoprotein (LDL)-receptor gene is associated with a mild clinical phenotype in a patient with heterozygous familial hypercholesterolaemia (FH). Hum. Mol. Genet. 4: 2125-2129.
9. Jensen, L. G., H. K. Jensen, H. Nissen, K. Kristiansen, O. Faergeman, L. Bolund, and N. Gregersen. 1996. An LDL receptor promoter mutation in a heterozygous FH patient with dramatically skewed ratio between the two allelic mRNA variants. Hum. Mutat. 7: 82-84.
10. Van Wingerden, J. J. 1981. Primary familial hypercholesterolaemia in a South African black. A case report. 1981. S. Afr. Med. J. 60: 554-556.
11. Jones, K. A., K. R. Yamamoto, and R. Tjian. 1985. Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro. Cell. 42: 559-572.
12. Coetzee, G. A., J. J. van Wingerden, and D. R. van der Westhuyzen. 1985. Low density lipoprotein receptor deficiency resulting in familial hypercholesterolaemia in a black man. S. Afr. Med. J. 67: 259-262.
13. Lloyd, D. B., and J. F. Thompson. 1995. Transcriptional modulators affect in vivo protein binding to the LDL receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase promoters. J. Biol. Chem. 270: 25812-25818.
14. Ellsworth, J. L., D. B. Lloyd, A. J. Carlstrom, and J. F. Thompson. 1995. Protein binding to the LDLR promoter in vivo is differentially affected by gene activation in primary human cells. J. Lipid. Res. 36: 383-393.
15. Sanchez, H. B., L. Yieh, and T. F. Osborne. 1995. Cooperation by sterol regulatory element-binding protein and Sp1 in sterol regulation of low density lipoprotein receptor gene. J. Biol. Chem. 270: 1161-1169.
16. Yieh, L., H. B. Sanchez, and T. F. Osborne. 1995. Domains of transcription factor Sp1 required for synergistic activation with sterol regulatory element binding protein 1 of LDLR promoter. Proc. Natl. Acad. Sci. USA. 92: 6102-6106.
17. Vermaak, W. J. H., J. B. Ubbink, R. Delport, P. J. Becker, S. H. Bissbort, and J. P. J. Ungerer. 1991. Ethnic immunity to coronary heart disease? Atherosclerosis. 789: 155-162.